Related Experiment Video
Updated: May 16, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Serum iron levels predict mortality risk in hypertensive patients: A prospective cohort study
Ziliang Ye1, Manyun Long1, Lang Li1
1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Insights
Higher serum iron levels are linked to reduced mortality risk in hypertensive patients. This association is partly explained by body mass index, serum creatinine, and lipid profiles, indicating complex interactions.
Area of Science:
- Cardiovascular Medicine
- Metabolic Health
- Clinical Biochemistry
Background:
- Hypertension is a major risk factor for mortality.
- The role of serum iron levels in hypertensive patients remains incompletely understood.
- Investigating iron's impact can reveal new therapeutic targets.
Purpose of the Study:
- To examine the association between serum iron levels and mortality risk in individuals with hypertension.
- To explore potential mediating factors in the relationship between serum iron and mortality.
Main Methods:
- A cohort study involving 15,181 hypertensive patients.
- Patients were categorized into four groups based on serum iron levels.
- Survival analysis and mediation analysis were employed to assess mortality risks and mediating factors.
Main Results:
- A significant inverse relationship was observed between serum iron levels and both all-cause and cardiovascular mortality.
- Higher quartiles of serum iron were associated with substantially lower mortality risks compared to the lowest quartile.
- Body mass index, serum creatinine, and lipid profiles partially mediated the effect of serum iron on mortality.
Conclusions:
- Elevated serum iron levels correlate with decreased mortality risks in hypertensive patients.
- Metabolic factors (BMI, lipids) and renal function (serum creatinine) play a mediating role.
- These findings suggest a complex interplay influencing mortality in hypertensive individuals.
Background And Aim:
This study aimed to investigate the relationship between serum iron levels and mortality risk in hypertensive patients.
Methods And Results:
A total of 15,181 hypertensive patients were included and stratified into four groups based on serum iron levels (Quartile 1 to Quartile 4). Patients were followed for an average of 85.24 ± 1.16 months. The proportions of all-cause mortality across Quartiles 1 through 4 were 16.96 %, 14.65 %, 13.47 %, and 12.15 %, respectively (p < 0.001), while the cardiovascular mortality rates were 5.06 %, 3.67 %, 3.46 %, and 2.84 %, respectively (p < 0.001). After adjusting for confounders, the risks of all-cause and cardiovascular mortality were significantly lower in Quartile 2 (hazard ratio [HR] = 0.80, p = 0.060; HR = 0.57, p = 0.004), Quartile 3 (HR = 0.76, p = 0.050; HR = 0.58, p = 0.010), and Quartile 4 (HR = 0.64, p < 0.001; HR = 0.45, p < 0.001) compared to Quartile 1. Restricted cubic spline regression revealed a significant negative association between serum iron levels and the risks of all-cause and cardiovascular mortality. Additionally, mediation analysis showed that body mass index (BMI), serum creatinine, and lipid profile partially mediated the effect of serum iron on mortality risk.
Conclusions:
Elevated serum iron levels were related to lower risks of mortality in hypertensive patients. BMI, serum creatinine, and lipid profile mediated this relationship, suggesting a potential interplay between metabolic and renal factors in modulating the effect of serum iron on mortality.
More Related Videos
04:36Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
Related Concept Videos
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Errors occurring during blood pressure monitoring
Several factors...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Factors affecting Blood pressure
Physiological Factors:
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Pre-Procedural Guidelines for Assessing Blood Pressure